Nxera PharmaNxera Pharma Co., Ltd.4565東証プライム医薬品FY ending Dec 2023, consolidated, IFRS
Revenue changed -18.0% from the prior year.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2018 | — | —× | -3.8% | —× | — |
| 2018 | — | —× | -10.1% | —× | — |
| 2021 | — | —× | 1.0% | —× | — |
| 2022 | — | —× | 0.4% | —× | — |
| 2023 | — | —× | -5.6% | —× | — |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
| Item | FY ending Mar 2018 | FY ending Dec 2018 | FY ending Dec 2021 | FY ending Dec 2022 | FY ending Dec 2023 |
|---|---|---|---|---|---|
| Revenue | 6,955 | 2,872 | 17,712 | 15,569 | 12,766 |
| Cost of revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| SG&A | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Pretax income | -3,702 | -7,243 | 433 | 1,078 | -10,680 |
| Income tax | — | — | — | — | — |
| Net income attributable to owners | -2,654 | -5,977 | 1,017 | 382 | -7,193 |
| Operating margin | — | — | — | — | — |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
| Item | FY ending Mar 2018 | FY ending Dec 2018 | FY ending Dec 2021 | FY ending Dec 2022 | FY ending Dec 2023 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥28.3B | ¥18.8B | ¥60.1B | ¥66.6B | ¥49.1B |
| Total assets | ¥69.5B | ¥59B | ¥97B | ¥99.4B | ¥157.2B |
| Net assets | — | ¥41.6B | — | — | ¥66.8B |
EDINET (FSA Japan)
有価証券報告書－第36期(2025/01/01－2025/12/31)
EDINET (FSA Japan)
有価証券報告書－第33期(2022/01/01－2022/12/31)
EDINET (FSA Japan)
有価証券報告書－第32期(令和3年1月1日－令和3年12月31日)
EDINET (FSA Japan)
有価証券報告書－第31期(令和2年1月1日－令和2年12月31日)
Extracted from XBRL: 10 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.